|
|
|
Print this page
|
SUNDAY |
OCTOBER 19 |
|
|
5:30pm -
8:00pm |
RECEPTION & WELCOME
Offices of Foley & Lardner
Washington Harbor |
|
|
|
MONDAY |
OCTOBER 20 |
|
|
|
7:30am -
8:00am |
BREAKFAST
Dahlgren Courtyard |
|
|
8:00am -
8:15am |
Introductory Remarks
All sessions - Healy Building's historic Gaston Hall
|
|
|
8:15am -
12:00pm |
Decisions and Their Consequences in Life Science |
|
|
8:15am |
The Big Picture: Science and Public Policy |
|
|
Jennie Hunter-Cevera, Ph.D.
President
University of Maryland Biotechnology Institute
Member of the Board of Directors:
EntreMed, Inc. (Nasdaq: ENMD) |
|
Eve Slater, M.D.
Former Assistant Secretary of Health
Department of Health and Human Services
Former Senior Vice President
Merck Research Laboratories |
|
9:30am |
Introduction by:
|
10:15am |
BREAK
Healy Corridors - 3rd & 4th Floors |
10:30am |
Healthcare: Who Decides And Who Pays?
|
Paul Auerbach, M.D., Session Chair
Chief Operating Officer
KAI Pharmaceuticals, Inc.
Member of the Board of Directors:
Curative Health Services, Inc.
(Nasdaq: CURE) |
|
Nancy Ann DeParle
Senior Advisor
JP Morgan Partners
Adjunct Professor, The Wharton School
University of Pennsylvania
and former Administrator
Health Care Financing Admin.(HCFA)
Member of the Board of Directors:
Accredo Health, Inc. (Nasdaq: ACDO)
Cerner Corporation (Nasdaq: CERN)
DaVita Inc. (NYSE: DVA)
Guidant Corporation (NYSE: GDT)
Specialty Laboratories (NYSE: SP)
Triad Hospitals Inc. (NYSE: TRI) |
|
Scott Fassbach
Chief Research Officer
The Advisory Board Company
(Nasdaq: ABCO) |
|
|
|
|
|
12:00pm -
1:30pm |
LUNCH
Copley Formal Lounge
12:30pm Introduction by:
|
|
|
|
1:30pm -
3:15pm |
Two Visions of Healthcare's Future:
Personalized and Preventive Medicine
|
Michael Zasloff, M.D., Ph.D., Session Chair
Dean of Research and Translational Science
Georgetown University Medical Center
Member of the Board of Directors:
Novozyme A/S (CSE: NZYM B) |
|
Juan Enriquez
Chairman & Chief Executive Officer
Biotechonomy
Member of the Board of Directors:
Cabot Microelectronics Corporation (Nasdaq: CCMP) |
|
Gilbert S. Omenn, M.D., Ph.D.
Professor of Internal Medicine, Human Genetics, &
Public Health
University of Michigan
Member of the Board of Directors:
Amgen Corporation (Nasdaq: AMGN)
Rohm and Haas Company (NYSE: ROH) |
|
Ralph Snyderman, M.D.
President and Chief Executive Officer
Duke University Health System
Member of the Board of Directors:
Cardiome Pharma Corp (Toronto: COM)
Procter & Gamble Company (NYSE: PG)
Science Applications International Corp. (SAIC) |
|
J. Craig Venter, Ph.D.
President & Chairman
The Center for the Advancement of Genomics
President & Chairman
Institute for Biologial Energy Alternatives |
|
|
|
|
3:15pm -
3:45pm |
BREAK
Healy Corridors - 3rd & 4th Floors |
|
|
|
3:45pm -
5:00pm |
Drug Development:
The Challenges of Turning Research into Reality
|
Carl Feldbaum, Session Chair
President
The Biotechnology Industry Organization (BIO) |
|
James A. Geraghty
Senior Vice President, International Development
Genzyme Corporation
Member of the Board of Directors:
GTC Biotherapeutics (Nasdaq: GTCB) |
|
Carl C. Peck, M.D., Ph.D.
Professor of Pharmacology and Medicine &
Director, Center for Drug Development Science
Georgetown University
Member of the Board of Directors:
Ligand Pharmaceuticals, Inc. (Nasdaq: LGND) |
|
|
|
|
6:15pm -
9:00pm |
EVENING ACTIVITIES
The Fairmont Hotel, Ballroom
7:45pm |
Introduction to Keynote |
|
|
|
|
TUESDAY |
OCTOBER 21 |
|
|
|
|
7:30am -
8:00am |
BREAKFAST
Dahlgren Courtyard |
|
|
|
8:15am -
9:30am |
Financing the Life Sciences:
The Capital Markets & Other Methods of Financing
Introduction by:
|
Joel S. Marcus
Chief Executive Officer
Alexandria Real Estate Equities, Inc. |
|
G. Steven Burrill
Chief Executive Officer
Burrill & Company
Chairman of the Board of Directors:
Paradigm Genetics, Inc. (Nasdaq: PDGM)
Member of the Board of Directors
Depomed, Inc. (AMEX: DMI)
Third Wave Technologies Inc. (Nasdaq: TWTI) |
|
Alfred R. Berkeley, III
Chairman of the Board of Directors
Community of Science, Inc.;
former Vice-Chairman of the Board of Directors
The Nasdaq Stock Market, Inc. |
|
|
|
|
9:30am -
10:15am |
FDA COMMISSIONER KEYNOTE
Introduction by:
|
Daniel D. Sedmak, M.D.
Executive Vice President
Health Sciences & Executive Dean
School of Medicine, Georgetown University |
|
|
|
|
10:15am -
10:45am |
BREAK
Healy Corridors - 3rd & 4th Floors |
|
|
|
10:45am -
11:15am |
REMARKS
|
|
|
|
11:15am -
12:30pm |
The Life Science and Their Potential Role in Solving Global Problems
|
Cynthia P. Schneider, Ph.D., Moderator
Director, Life Sciences and Society Initiative
Georgetown University
Member of the Supervisory Board
Royal Ahold (Euronext: AHLN)
(NYSE: AHO US-ADRs) |
|
Anatole F. Krattiger, M.Phil., Ph.D.
Adjunct Professor & Director, The Strategic World
Initiative for Technology Transfer (SWIFTT)
College of Agriculture and Life Sciences
Cornell University;
President
bioDevelopments LLC |
|
Michael Magee, M.D.
Director, Pfizer Medical Humanities Initiative
Senior Medical Advisor
Pfizer Inc. (NYSE: PFE) |
|
Paul V. Tebo, Ph.D.
Corporate Vice President, Safety, Health and Environment
E.I. du Pont de Nemours and Company (NYSE: DD) |
|
|
|
|
12:30pm -
1:30pm |
LUNCH
Copley Formal Lounge
1:00pm Panel:
INSIDE THE MIND OF A VENTURE CAPITALIST:
|
Bruce W. Jenett, Moderator
Co-Chair, Life Science & Technology National Practices Group
Heller Ehrman White & McAuliffe |
|
|
|
|
  Venture Connections Afternoon For VC Sponsors Only
An Opportunity for Early-Stage Companies
|
|
|
The afternoon is by invitation only to private companies and is for the making of presentations to a select group of venture capitalists. |
|
|
|
1:45pm - 4:00pm |
Private Companies
 |
|
10/17/2003 |
|
|
